Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i


i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Filetype[PDF-108.58 KB]


  • English

  • Details:

    • Description:
      Updated Sept. 19, 2020 Summary of Recent Changes Revisions made on September 19, 2020 include: • New link under Resources to DLS Preparing and Supporting Laboratories Responding to COVID-19 page Revisions made on August 7, 2020 include: • Standard Precautions Revisions made on July 16, 2020 include: • Added DOT resources to Specimen Packing and Shipping and Resource section Revisions made on July 13, 2020 to update: • Language for virus isolation Revisions made on June 3, 2020 include: • Added anatomic pathology guidance for COVID-19 • Updated Point-of-Care testing guidance for COVID-19 Revisions made on May 11, 2020 include recommendations for: • Point-of-Care testing guidance for COVID-19 Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.
    • Content Notes:
      General Guidance -- Routine Viral Testing -- Anatomic Pathology -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
    • Document Type:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov